First Patient Dosed in Trial of INT230-6 For Triple-Negative Breast Cancer
Nov 4, 2024 · The first patient has been dosed in a phase 2 clinical trial studying a potential new treatment for localized triple-negative breast cancer (TNBC). Intensity Therapeutics, a …
New study finds triple-negative breast cancer tumors with an …
Apr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may …
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative …
6 days ago · HealthDay News — For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, according to a study published …
Antibody-based treatment for the most aggressive type of breast cancer ...
Nov 4, 2024 · "Dr. Steven Rosen, an executive vice president at City of Hope, proposed that we examine samples from patients with the most aggressive type of breast tumors—triple …
Fighting triple-negative breast cancer is hard, but not impossible
Oct 25, 2024 · Most recently, breast cancer doctors say they may have found a new way to fight triple-negative breast cancer– one of the most devasting subtypes of cancer. NBC 5 health …
Understanding triple-negative breast cancer and its treatment
Jan 3, 2024 · Triple-negative breast cancer, also called basal-like breast cancer, is a subtype that isn't affected by hormones or the HER2 gene. It grows rapidly, is more likely to spread beyond …
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
Jul 20, 2022 · Pembrolizumab monotherapy has shown durable antitumor activity in advanced triple-negative breast cancer, 6-9 particularly as first-line therapy, with improved clinical …
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer ...
WASHINGTON (July 17, 2023) — How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the …
Pembrolizumab for Advanced Triple-Negative Breast Cancer
August 9, 2022, by Edward Winstead. Adding the immunotherapy drug pembrolizumab (Keytruda) to chemotherapy can help some patients with advanced triple-negative breast cancer live …
FDA Approves Trodelvy (Sacituzumab govitecan-hziy) for Triple Negative ...
Apr 29, 2020 · The US Food and Drug Administration (FDA) approved a new type of therapy for triple-negative breast cancer that has spread to other parts of the body and hasn’t responded …